Laura Sutcliffe
Stock Analyst at Citigroup
(0.95)
# 4,163
Out of 5,182 analysts
12
Total ratings
33.33%
Success rate
-9.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $345 → $340 | $222.02 | +53.14% | 5 | Apr 9, 2026 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $10.40 | +116.35% | 4 | Feb 24, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $783.74 | -50.24% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.55 | - | 2 | Dec 20, 2019 |
ResMed
Apr 9, 2026
Maintains: Buy
Price Target: $345 → $340
Current: $222.02
Upside: +53.14%
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $10.40
Upside: +116.35%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $783.74
Upside: -50.24%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.55
Upside: -